Vortex “As a clinician, I am excited about accessing the cancer biology of patient’s through CTCs. Vortex’s technology provides the best source of CTCs to aid in the diagnostic and treatment decisions we face every day.” – Dr. Jonathan Goldman, MD, Director of Clinical Trials in Thoracic Oncology, Associate Director of Drug Development at UCLA “Improving CTCs recovery along with high cellular purity while maintaining viability have tremendous value for translational research and clinical diagnostic applications. The VTX-1 holds the potential to revolutionize blood-based diagnostics.” - Pr. Massimo Cristofanilli, MD, FACP, Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine Wanda J. Cribbs, Lead Gartner Analyst Population Health & Analytics says: "Wanda's recent HRS press release really stands out. Delivering those results and having a client publicly share credit with their vendor is rare and says a lot. We at Gartner will have our eyes on Wanda in 2018"

Analyst Coverage

Company Analyst

Maxim Jacobs
T: +44 (0)20 3681 2527



Click on headlines below to download research

Commercial progress across portfolio December 15 2017

Edison NetScientific  Development outlook 11 October 2017

Edison NetScientific  Clinical update 13 July 2017

Edison NetScientific  Earnings update 5 May 2017

On deck for multiple 2017 launches

NetScientific | 09/12/2016

NetScientific’s subsidiaries have made multiple advances on regulatory and commercial fronts. ProAxsis and Vortex will both be launching their first …read more

Executive Interview – NetScientific | 08/11/2016

NetScientific is a healthcare investment company with a portfolio of digital health, diagnostic and therapeutic investees. In 2015 the company realigned…

Transatlantic healthcare technologies

Edison NetScientific  Operational update 9 December 2016

NetScientific | 26/08/2016

NetScientific is a healthcare investment company with a portfolio of digital health, diagnostic, and therapeutic investees. In 2015 the company realigned read more

Edison NetScientific  Portfolio Initiation of coverage 26 August 2016

Edison NetScientific  Portfolio overview 13 June 2016


Analyst Coverage - NetScientific